We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

111 hedge funds and large institutions have $354M invested in Five Prime Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

4% more funds holding

Funds holding: 107 → 111 (+4)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

30% less capital invested

Capital invested by funds: $504M → $354M (-$150M)

100% less call options, than puts

Call options by funds: $3K | Put options by funds: $634K

Holders
111
Holders Change
+4
Holders Change %
+3.74%
% of All Funds
3.1%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
20
Increased
40
Reduced
34
Closed
16
Calls
$3K
Puts
$634K
Net Calls
-$631K
Net Calls Change
-$221K

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$15.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$14M
3
GPP
Great Point Partners
Connecticut
+$11.8M
4
AC
Armistice Capital
New York
+$10.9M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$7.22M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$10.2M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$7.33M
3
BI
BVF Inc
California
-$5.98M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$4.98M
5
AAM
Aureus Asset Management
Massachusetts
-$4.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
BJ
101
BlackRock Japan
Japan
$16K -$1.57K -73 -6%
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
$15K +$20.7K +964 New
Fifth Third Bancorp
103
Fifth Third Bancorp
Ohio
$8K – – –
BlackRock
104
BlackRock
New York
$7K – – –
US Bancorp
105
US Bancorp
Minnesota
$6K – – –
Bank of America
106
Bank of America
North Carolina
$5K -$511K -23,787 -99%
NCM
107
Nelson Capital Management
California
$5K – – –
MA
108
MUFG Americas
New York
$2K – – –
TJHA
109
Thomas J. Herzfeld Advisors
Florida
$1K +$1.07K +50 New
Manulife (Manufacturers Life Insurance)
110
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$221 +$9.97K +464 +3%
Bank of Montreal
111
Bank of Montreal
Ontario, Canada
– -$7.33M -341,198 -100%
BI
112
BVF Inc
California
– -$5.98M -240,597 Closed
TC
113
TFS Capital
Pennsylvania
– -$1.02M -40,913 Closed
SGAM
114
Smith Group Asset Management
Texas
– -$990K -39,850 Closed
PP
115
PDT Partners
New York
– -$837K -33,700 Closed
SO
116
STRS Ohio
Ohio
– -$284K -13,200 Closed
American Century Companies
117
American Century Companies
Missouri
– -$316K -12,716 Closed
VOYA Investment Management
118
VOYA Investment Management
Georgia
– -$316K -12,705 Closed
Jane Street
119
Jane Street
New York
– -$297K -11,939 Closed
UBS AM
120
UBS AM
Illinois
– -$238K -9,600 Closed
SCA
121
Secor Capital Advisors
New York
– -$215K -8,662 Closed
Two Sigma Advisers
122
Two Sigma Advisers
New York
– -$214K -8,600 Closed
PCM
123
Prelude Capital Management
New York
– -$62K -2,500 Closed
UBS Group
124
UBS Group
Switzerland
– -$22K -898 Closed
TWA
125
TCI Wealth Advisors
Arizona
– -$12K -500 Closed
2 3 4
5
6

FPRX Hedge Fund Activity: Q3 2015 in Review

111 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q3 2015, worth a combined $354M — down 30% from $504M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new FPRX positions and 16 closed out — a net gain of 4 holders — while 40 added to existing stakes and 34 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $15.1M. The largest seller was Point72 Asset Management, cutting an estimated $10.2M.

  • 111 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q3 2015, up from 107 in Q2 2015.
  • Funds reported $354M of Five Prime Therapeutics, Inc. stock for Q3 2015, down 30% quarter-over-quarter.
  • 20 funds opened new Five Prime Therapeutics, Inc. positions in Q3 2015 and 16 closed out, a net change of +4 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q3 2015 was Adage Capital Partners, an estimated $15.1M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q3 2015 was Point72 Asset Management, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2015.